YOLFTbeta
Geron Corporation

Geron Corporation

GERN · NASDAQ · Healthcare / Biotechnology

0.97USD-0.02 (-2.41%)

Price History

Full chart

Market Stats

Previous Close0.994
Open0.99
Day Range0.95 – 0.99
52-Week Range1.04 – 2.01
Volume7.10M
Market Cap809.52M
P/E (TTM)0.00
Forward P/E65.36
EPS-0.11
Dividend Yield0.00%
Beta0.60
50-Day Avg1.45
200-Day Avg1.45

About

Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. The company's product pipeline includes RYTELO, a telomerase inhibitor for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia; IMerge which is in Phase 3 clinical trial for the treatment of lower-risk myelodysplastic syndromes; IMpactMF that is in Phase 3 for the treatment of relapsed/refractory myelofibrosis; Impress which is in Phase 2 clinical trial to treat higher risk myelodysplastic syndromes and acute myeloid leukemia (AML); IMproveMF which is in Phase 1 clinical trial for the treatment of frontline myelofibrosis; and IMAGINE which is in phase 1/2 clinical trial for the treatment of relapsed/refractory AML. Geron Corporation was incorporated in 1990 and is headquartered in Foster City, California.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Harout Semerjian
  • Employees258
  • Headquarters919 East Hillsdale Boulevard, Foster City, CA, United States, 94404, USA
  • Websitehttps://www.geron.com

Leadership

  • Mr. Harout SemerjianCEO, President & Director · b. 1970
  • Ms. Michelle J. RobertsonEVP, CFO, Treasurer and Principal Financial & Accounting Officer · b. 1967
  • Dr. Joseph Emile Eid M.D.Executive VP of Research & Development and Chief Medical Officer · b. 1967
  • Mr. Ahmed ElNawawiExecutive VP & Chief Commercial Officer · b. 1981
  • Mr. Shanthakumar TyavanagimattSenior VP & Chief Technical Officer
  • Ms. Dawn Schottlandt CFASenior Vice President of Investor Relations & Corporate Affairs
  • Mr. Timothy Williams J.D.Executive VP, Chief Legal Officer & Corporate Secretary · b. 1977
  • Ms. Aron FeingoldVice President of Investor Relations & Corporate Communications
  • Ms. Shannon T. OdamExecutive VP & Chief People Officer · b. 1975
  • Mr. Bryan RidgellSenior VP of Portfolio & Project Management and Chief of Staff

Financials

Income Statement

Currency: USD1996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue5.30M7.30M6.80M5.40M6.61M3.62M1.25M1.17M1.05M290.00K3.28M7.62M2.80M1.73M3.56M2.44M2.71M1.28M1.15M36.37M6.16M1.06M1.07M460.00K253.00K1.39M596.00K237.00K76.99M183.88M
Growth (%)-+37.74%-6.85%-20.59%+22.39%-45.23%-65.52%-5.93%-10.31%-72.46%+1030.00%+132.59%-63.22%-38.42%+106.43%-31.57%+11.12%-52.64%-10.13%+3054.47%-83.06%-82.72%+0.09%-56.85%-45.00%+450.59%-57.21%-60.23%+32386.92%+138.83%
Cost of Revenue-1.20M-1.60M-1.70M-3.70M-4.65M34.51M29.30M26.64M33.38M42.14M49.21M68.79M67.83M70.21M78.12M91.53M25.18M9.13M8.90M9.57M14.70M8.44M12.72M39.26M50.05M783.00K868.00K123.74M1.26M4.75M
Gross Profit6.50M8.90M8.50M9.10M11.26M3.62M1.25M1.17M1.05M290.00K3.28M7.62M2.80M1.73M3.56M2.44M-22.47M-7.85M-7.75M26.80M-8.53M-7.37M-11.66M460.00K-49.80M1.39M596.00K237.00K75.74M179.14M
Gross Margin122.64%121.92%125.00%168.52%170.40%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%-829.42%-611.93%-671.99%73.68%-138.48%-692.21%-1093.53%100.00%-19683.40%100.00%100.00%100.00%98.37%97.42%
Operating Expense18.70M19.80M21.10M29.90M37.47M38.64M36.95M31.35M82.34M38.00M50.64M70.46M69.85M71.96M114.73M98.55M49.29M31.11M28.56M27.36M22.11M21.88M19.42M72.97M27.11M115.39M139.15M194.18M249.47M232.97M
Operating Income-12.20M-10.90M-12.60M-20.80M-26.21M-35.02M-35.70M-30.18M-81.28M-37.71M-47.36M-62.84M-67.04M-70.23M-111.17M-96.12M-71.76M-38.96M-36.31M-559.00K-30.65M-29.25M-31.07M-72.50M-76.91M-114.00M-138.55M-193.94M-173.73M-53.84M
Operating Margin-230.19%-149.32%-185.29%-385.19%-396.61%-967.38%-2860.58%-2570.70%-7719.37%-13003.45%-1445.22%-824.44%-2391.87%-4069.18%-3120.04%-3942.41%-2648.87%-3036.48%-3149.35%-1.54%-497.34%-2746.95%-2914.92%-15761.96%-30400.40%-8183.70%-23246.64%-81832.91%-225.64%-29.28%
EBITDA-11.00M-9.30M-10.90M-17.10M-21.56M-30.65M-31.11M-26.06M-32.23M-35.85M-47.36M-62.84M-59.91M-68.29M-109.67M-95.04M-67.82M-38.06M-35.62M803.00K-30.57M-29.18M-26.96M-71.73M-76.75M-111.59M-134.15M-174.78M-154.85M-51.92M
EBITDA Margin-207.55%-127.40%-160.29%-316.67%-326.21%-846.66%-2492.79%-2219.59%-3060.78%-12361.72%-1445.22%-824.44%-2137.39%-3956.43%-3078.02%-3898.11%-2503.43%-2966.41%-3089.59%2.21%-496.02%-2739.81%-2528.89%-15593.26%-30337.94%-8010.70%-22508.56%-73747.68%-201.12%-28.24%
Net Income-10.70M-9.60M-10.80M-46.40M-45.83M-42.07M-33.91M-29.88M-80.41M-33.53M-31.36M-36.70M-62.02M-70.18M-111.38M-96.85M-68.88M-38.38M-35.67M46.00K-29.54M-27.92M-27.02M-63.55M-75.62M-116.11M-141.90M-184.13M-174.57M-85.78M
Net Income Margin-201.89%-131.51%-158.82%-859.26%-693.49%-1162.24%-2716.99%-2545.40%-7635.80%-11561.38%-957.13%-481.46%-2212.67%-4066.28%-3125.93%-3972.64%-2542.67%-2991.35%-3093.67%0.13%-479.34%-2621.22%-2534.43%-13815.43%-29888.14%-8335.39%-23808.89%-77690.72%-226.73%-46.65%
R&D14.30M15.10M15.60M20.60M23.55M29.02M31.57M25.55M30.08M35.08M41.23M54.62M53.66M57.62M61.69M69.32M51.37M23.16M20.71M17.83M18.05M11.03M13.43M52.07M51.49M85.73M95.52M125.05M103.74M73.72M
R&D as % of Total Revenue269.81%206.85%229.41%381.48%356.30%801.60%2529.89%2176.41%2856.98%12096.55%1258.29%716.66%1914.52%3338.18%1731.32%2843.15%1896.20%1804.75%1795.92%49.03%292.88%1035.96%1260.04%11320.00%20350.99%6154.13%16026.51%52762.03%134.74%40.09%
Interest Expense400.00K0900.00K012.28M1.00M757.00K736.00K672.00K464.00K130.00K102.00K93.00K143.00K98.00K237.00K233.00K56.00K82.00K88.00K83.00K77.00K00760.00K3.74M6.88M8.31M18.50M32.66M
Interest Expense % of Total Revenue7.55%0.00%13.24%0.00%185.87%27.73%60.66%62.69%63.82%160.00%3.97%1.34%3.32%8.29%2.75%9.72%8.60%4.36%7.11%0.24%1.35%7.23%0.00%0.00%300.40%268.49%1154.70%3507.17%24.03%17.76%

Balance Sheet

Currency: USD1996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets28.80M26.10M44.50M63.70M114.03M96.23M60.67M118.11M131.87M201.24M220.80M218.90M176.22M180.38M233.58M160.05M99.80M67.34M172.51M148.76M130.25M110.31M185.28M165.52M270.73M226.03M190.57M394.08M593.78M570.54M
Total Liabilities5.20M5.00M11.70M37.50M50.11M34.69M30.93M11.79M9.81M10.54M46.88M13.22M7.76M7.80M40.85M13.44M14.15M7.59M41.80M6.63M7.87M6.52M7.55M30.36M59.78M99.62M110.58M146.13M313.46M344.67M
Total Equity23.60M21.10M32.80M26.20M63.92M61.54M29.74M106.32M122.06M190.71M173.92M205.67M168.46M172.58M192.74M146.60M85.65M59.76M130.71M142.13M122.38M103.80M177.73M135.16M210.95M126.42M80.00M247.95M280.32M225.87M
Cash12.40M4.10M16.40M7.80M29.98M18.77M4.60M12.82M9.85M96.63M135.88M146.03M109.35M34.60M45.97M16.11M22.86M12.99M43.06M21.52M13.08M16.60M10.84M13.64M9.93M34.87M56.84M70.02M79.02M79.44M
Total Debt2.80M2.30M9.00M18.30M33.36M17.42M26.02M6.19M3.25M55.00K-------------2.55M29.72M55.00M55.75M85.90M121.72M251.57M
Net Debt-9.60M-1.80M-7.40M10.50M3.37M-1.35M21.42M-6.63M-6.60M-96.58M-135.88M-146.03M-109.35M-34.60M-45.97M-16.11M-22.86M-12.99M-43.06M-21.52M-13.08M-16.60M-10.84M-11.09M19.79M20.13M-1.09M15.88M42.70M172.13M

Cash Flow

Currency: USD1996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-9.90M-7.90M-7.80M-13.60M-13.61M-22.42M-31.34M-24.40M-25.93M-20.61M-26.38M-26.63M-41.98M-43.37M-44.29M-62.39M-55.15M-36.68M9.35M-24.20M-18.37M-20.56M-21.01M-43.83M-66.65M-95.56M-127.38M-167.74M-218.62M-111.04M
Investing Cash Flow-10.00M-6.30M-7.60M-12.90M-31.51M3.89M17.29M-54.54M-18.16M12.96M16.88M16.04M5.47M-83.00M-48.45M32.14M60.95M21.05M-77.90M73.00K8.76M22.97M-77.72M27.40M-105.32M71.95M62.07M-180.32M-106.00M107.25M
Financing Cash Flow19.80M5.90M27.60M18.00M67.26M7.32M-116.00K87.15M41.11M94.44M48.75M20.73M-162.00K51.63M104.11M386.00K150.00K6.55M98.36M2.58M1.17M1.11M92.97M19.50M168.35M48.56M87.26M362.02M334.37M2.27M
Capital Expenditure1.10M700.00K1.00M2.70M1.18M1.11M328.00K411.00K1.53M1.64M779.00K2.99M2.34M1.44M836.00K612.00K862.00K3.00K131.00K90.00K57.00K16.00K16.00K413.00K401.00K207.00K431.00K830.00K680.00K49.00K
Free Cash Flow-11.00M-8.60M-8.80M-16.30M-14.79M-23.53M-31.67M-24.81M-27.45M-22.25M-27.16M-29.62M-44.32M-44.81M-45.13M-63.00M-56.01M-36.68M9.22M-24.29M-18.43M-20.56M-21.02M-44.24M-67.05M-95.76M-127.81M-168.57M-219.30M-111.09M
Dividends Paid--------44.97M--9.08M--6.00K0000000--------
FCF to OCF111.11%108.86%112.82%119.85%108.68%104.93%101.05%101.68%105.89%107.97%102.95%111.23%105.57%103.31%101.89%100.98%101.56%100.01%98.60%100.37%100.31%100.00%100.08%100.94%100.60%100.22%100.34%100.49%100.31%100.04%
Dividend Paid to FCF---------163.83%---30.66%---0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%--------

Earnings

Report DateMar 7, 1997May 9, 1997Aug 11, 1997Nov 12, 1997Mar 2, 1998Mar 31, 1998Aug 7, 1998Nov 13, 1998Mar 31, 1999Jun 30, 1999Sep 30, 1999Mar 31, 2000Jun 30, 2000Sep 30, 2000Dec 31, 2000Mar 31, 2001Jun 30, 2001Sep 30, 2001Feb 26, 2002May 6, 2002Jun 30, 2002Sep 30, 2002Dec 31, 2002Mar 31, 2003Jul 30, 2003Nov 12, 2003Feb 27, 2004Apr 29, 2004Jul 30, 2004Oct 29, 2004Feb 25, 2005Apr 29, 2005Aug 5, 2005Nov 4, 2005Feb 28, 2006Apr 28, 2006Jul 31, 2006Oct 30, 2006Mar 16, 2007Apr 27, 2007Jul 30, 2007Oct 30, 2007Feb 27, 2008Apr 29, 2008Jul 30, 2008Oct 30, 2008Feb 26, 2009Apr 29, 2009Jul 30, 2009Oct 29, 2009Feb 25, 2010Apr 28, 2010Jul 29, 2010Oct 28, 2010Feb 24, 2011Apr 27, 2011Jul 28, 2011Nov 3, 2011Mar 7, 2012May 2, 2012Jul 31, 2012Oct 30, 2012Mar 12, 2013Apr 25, 2013Aug 8, 2013Nov 7, 2013Mar 17, 2014May 1, 2014Aug 11, 2014Nov 3, 2014Mar 3, 2015Apr 30, 2015Aug 5, 2015Nov 5, 2015Feb 25, 2016May 5, 2016Aug 3, 2016Nov 3, 2016Mar 1, 2017May 9, 2017Aug 9, 2017Nov 1, 2017Mar 16, 2018May 10, 2018Jul 31, 2018Nov 1, 2018Mar 7, 2019May 2, 2019Aug 1, 2019Nov 6, 2019Mar 12, 2020May 28, 2020Aug 6, 2020Nov 5, 2020Mar 11, 2021May 10, 2021Aug 16, 2021Nov 9, 2021Mar 10, 2022May 9, 2022Aug 11, 2022Nov 3, 2022Mar 16, 2023May 11, 2023Aug 3, 2023Nov 2, 2023Feb 28, 2024May 2, 2024Aug 8, 2024Nov 7, 2024Feb 26, 2025May 7, 2025Aug 6, 2025Nov 5, 2025Feb 25, 2026May 6, 2026Aug 5, 2026Nov 4, 2026
EPS Estimate-0.25-0.20-0.15-0.23-0.23--0.33-0.35-----------0.46-0.25-----0.31-0.30----0.21-0.21--0.18-0.13-0.17-0.16-0.15-0.16-0.17-0.17-0.20-0.20-0.18-0.18-0.20-0.17-0.21-0.20-0.19-0.21-0.17-0.20-0.19-0.20-0.19-0.19-0.17-0.18-0.20-0.20-0.15-0.14-0.14-0.08-0.07-0.06-0.07-0.06-0.06-0.050.05-0.06-0.060.18-0.05-0.05-0.06-0.06-0.06-0.05-0.05-0.05-0.05-0.05-0.04-0.05-0.04-0.05-0.10-0.13-0.19-0.12-0.06-0.06-0.06-0.08-0.09-0.09-0.08-0.10-0.09-0.09-0.12-0.10-0.08-0.10-0.10-0.09-0.10-0.08-0.05-0.04-0.03-0.03-0.03-0.02-0.01-0.01
EPS Actual-0.31-0.44-0.17-0.18-0.14-0.17-0.22-0.25-0.25-1.87-0.42-0.35-0.77-0.23-0.54-0.34-0.28-0.42-0.85-0.43-0.37-0.29-0.29-0.32-0.32-0.15-0.21-1.28-0.20-0.23-0.20-0.18-0.06-0.21-0.14-0.14-0.14-0.15-0.20-0.03-0.19-0.17-0.23-0.18-0.17-0.22-0.22-0.20-0.23-0.17-0.20-0.18-0.18-0.19-0.24-0.20-0.17-0.16-0.19-0.15-0.14-0.13-0.10-0.09-0.06-0.06-0.07-0.06-0.06-0.060.08-0.06-0.050.17-0.05-0.06-0.05-0.02-0.05-0.05-0.04-0.04-0.05-0.04-0.04-0.03-0.04-0.05-0.08-0.08-0.15-0.08-0.06-0.06-0.07-0.09-0.09-0.08-0.10-0.09-0.07-0.10-0.10-0.07-0.09-0.08-0.09-0.09-0.10-0.04-0.04-0.03-0.02-0.03-0.02-0.00-0.02-
Surprise-24.00%-120.00%-13.33%21.74%39.13%-33.33%28.57%-----------84.78%-72.00%-----3.23%50.00%----9.52%4.76%-66.67%-61.54%17.65%12.50%6.67%6.25%-17.65%82.35%5.00%15.00%-27.78%0.00%15.00%-29.41%-4.76%0.00%-21.05%19.05%-17.65%10.00%5.26%5.00%-26.32%-5.26%0.00%11.11%5.00%25.00%6.67%7.14%28.57%-12.50%14.29%0.00%0.00%0.00%0.00%-20.00%60.00%0.00%16.67%-5.56%0.00%-20.00%16.67%66.67%16.67%0.00%20.00%20.00%0.00%20.00%0.00%40.00%0.00%0.00%20.00%38.46%21.05%33.33%0.00%0.00%-16.67%-12.50%0.00%11.11%-25.00%10.00%22.22%-11.11%16.67%30.00%-12.50%20.00%10.00%0.00%0.00%50.00%23.28%25.00%33.33%0.00%24.29%75.50%-100.00%-
Timing-------------------After-hours---------Pre-marketPre-market-Pre-marketPre-market-Pre-marketPre-marketPre-marketPre-market-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursPre-marketAfter-hoursAfter-hours-After-hoursAfter-hours-After-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap809.52M
Enterprise Value659.72M
Trailing P/E0.00
Forward P/E65.36
PEG Ratio-2.38
Price / Sales3.96
Price / Book3.84
EPS-0.11
Book Value0.34
Revenue (TTM)204.56M
Gross Profit (TTM)119.67M
EBITDA-34.80M
Profit Margin-33.05%
Operating Margin-22.01%
Return on Equity-28.28%
Return on Assets-4.11%
Shares Outstanding642.47M
Shares Float556.32M
Beta0.60
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 9 analystsTarget 4.25
  • Strong Buy
    4
  • Buy
    2
  • Hold
    3

Ownership Breakdown

Institutions
76.63%
Insiders
0.08%
Retail / Other
23.29%

Top Institutional Holders

  • RA Capital Management, LLC
    63.77M9.93%
  • BlackRock Inc
    47.32M7.37%
  • Soleus Capital Management, L.P.
    42.81M6.66%
  • State Street Corp
    30.50M4.75%
  • Citadel Advisors Llc
    29.04M4.52%
  • Vanguard Capital Management, LLC
    26.67M4.15%
  • Point72 Asset Management, L.P.
    20.46M3.18%
  • ClearBridge Advisors, LLC
    19.62M3.05%
  • Eversept Partners, LP
    18.72M2.91%
  • Geode Capital Management, LLC
    13.67M2.13%
  • Morgan Stanley - Brokerage Accounts
    12.67M1.97%
  • Nantahala Capital Management, LLC
    11.22M1.75%
  • The Goldman Sachs Group Inc
    11.18M1.74%
  • Vivo Capital, LLC
    8.67M1.35%
  • Millennium Management LLC
    8.11M1.26%
  • Kynam Capital Management, LP
    6.84M1.06%

Top Fund Holders

  • State Street® SPDR® S&P® Biotech ETF
    23.02M3.58%
  • Vanguard MStar Total Stk Mkt Idx Invest
    20.45M3.18%
  • iShares Russell 2000 ETF
    14.26M2.22%
  • Vanguard Explorer Inv
    12.98M2.02%

Stock Splits

  • Jul 22, 2014529:500